Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes ...

Noxopharm (ASX:NOX) has reported its lupus medication in development, SOF-SKN, has passed first-stage in vitro safety tests ...

Mupirocin is a prescription treatment, and while this early study showed signs of decreasing inflammation, the study wasn't designed to see if it can decrease the rash of cutaneous lupus ...

“In addition to decreasing the inflammation by decreasing lesional staphylococcus aureus, the mupirocin treatment also lowered skin monocyte levels, which are important in driving cutaneous lupus,” ...